Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma

The treatment of patients with multiple myeloma usually includes many drugs including thalidomide, lenalidomide and bortezomib. Lovastatin and other inhibitors of HMG-CoA reductase demonstrated to exhibit antineoplasmatic and proapoptotic properties in numerous in vitro studies involving myeloma cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Hus, Marek, Grzasko, Norbert, Szostek, Marta, Pluta, Andrzej, Helbig, Grzegorz, Woszczyk, Dariusz, Adamczyk-Cioch, Maria, Jawniak, Dariusz, Legiec, Wojciech, Morawska, Marta, Kozinska, Justyna, Waciński, Piotr, Dmoszynska, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168480/
https://www.ncbi.nlm.nih.gov/pubmed/21698395
http://dx.doi.org/10.1007/s00277-011-1276-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168480/
https://www.ncbi.nlm.nih.gov/pubmed/21698395
http://dx.doi.org/10.1007/s00277-011-1276-2

Ejemplares similares